AUTHORS

Real Money authors - Steve Gelsi

Steve Gelsi

Steve Gelsi has covered Wall Street, private equity and the media business for Reuters, MarketWatch, Forbes, Adweek and other organizations. Gelsi is also author of the 2002 book How America Made a Fortune and Lost Its Shirt, which chronicles the 1990s dot-com boom. Additionally, Gelsi has written about the cannabis business since the 1990s.

Email Steve Gelsi

Recent Articles By The Author

Aurora Cannabis Shares Surge as Coca-Cola Confirms CBD Interest

A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.

Bankers Are Getting More Comfortable With Cannabis

Attitudes are changing, and the number of financial institutions serving the space is increasing, according to experts.

PE-Backed Hydroponic Equipment Specialist Hydrofarm Plans 2019 IPO

Equipment provider sees growth opportunities for cannabis business in U.S. and Canada.

Canada's Hexo Pursues Additional JV Cannabis Deals After Molson

Hexo is pursuing joint ventures in cosmetics, health care, candy, edibles, and vape companies.

Should Cannabis Investors Be Worried After the SEC's Warning?

The agency has swooped into the space with an investor alert and fraud case.

Cannabis Name Green Thumb Industries Eyes Big Boost From Opioid Substitute Law

New Illinois legislation could signal a potential tidal wave of growth in the budding industry.

Tilray Feeds Deal-Making Speculation on Analyst Call

Tilray reported a 95% jump in second-quarter revenue to $9.7 million, ahead of the Wall Street estimate of $9 million, in its first earnings release since it went public on July 19.

Family Offices Inject Capital Into Budding Cannabis Industry

Family offices, which manage billions of dollars and have much fewer restrictions on how they deploy capital, have been wading into the cannabis space with increasing frequency.

MedMen sees traction in California despite market challenges

Matt Karnes, the founder of cannabis industry analytics firm GreenWave Advisors, said that based on his estimates of public sales and dispensary data, MedMen is outpacing the statewide average between $200,000 and $250,000 quarterly revenue per store.

Bank of America, Goldman Sachs Get Behind Constellation Brands' Cannabis Play

The big banks lend support to the fast-growing cannabis market.

Email

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight